AMPAC Fine Chemicals (AFC), a wholly owned subsidiary of American Pacific, has joined Rx-360 as an active member.
Subscribe to our email newsletter
AFC is contributing to the Rx-360’s joint audit pilot program as the first US-based active pharmaceutical ingredient (API) manufacturer to be audited.
AMPAC quality and regulatory affairs vice president Jeff Robinson said they continue to invest in quality systems and this is demonstrated by the successful inspections by the FDA, KFDA and EMA.
AFC president Aslam Malik said the successful audits by various regulatory agencies coupled with AFC joining Rx-360 substantiates their commitment to Quality and to AFC’s Continuous Improvement Initiative.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.